| JYSZ2000001 | 螨变应原注射液 | | Injection | Biological Products | License Renew | 2020-01-23 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Allergopharma Gmbh & Co KG | Certificate Issued | 2021-07-15 | view |
| JYSZ2000002 | 螨变应原注射液 | | Injection | Biological Products | License Renew | 2020-01-23 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Allergopharma Gmbh & Co KG | Certificate Issued | 2021-07-15 | view |
| JXHL2100087 | Berzosertib注射液 | berzosertib | Injection | Chemical Drugs(1) | Import Drug Application | 2021-03-12 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2021-03-12 | view |
| JXHB2100026 | Tepotinib片 | tepotinib hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-03-03 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA;Merck Healthcare KGaA | In Review | 2021-03-02 | view |
| JXSL2000200 | Pergoveris Powder and solvent for solution for injection | follitropin alfa;lutropin alfa | Lyophilized | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSL2000203 | Pergoveris Solution for injection | follitropin alfa;lutropin alfa | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSL2000202 | Pergoveris Solution for injection | follitropin alfa;lutropin alfa | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSL2000201 | Pergoveris Solution for injection | follitropin alfa;lutropin alfa | Injection | Biological Products(3.1) | Import Drug Application | 2020-11-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Europe BV | In Review | 2020-11-10 | view |
| JXSB2000030 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products(1) | Supplementary Application | 2020-10-14 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Serono SpA;Merck Healthcare KGaA | In Review | 2020-10-13 | view |
| JYSB1800268 | 螨变应原注射液 | | Injection | Biological Products | Supplementary Application | 2018-12-10 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Allergopharma Gmbh & Co KG | Certificate Issued | 2020-09-16 | view |
| JYSB1800267 | 螨变应原注射液 | | Injection | Biological Products | Supplementary Application | 2018-12-10 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Allergopharma Gmbh & Co KG | Certificate Issued | 2020-09-10 | view |
| JYHB2000563 | Tepotinib片 | tepotinib hydrochloride | Tablet | Chemical Drugs(1) | Supplementary Application | 2020-05-16 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2020-05-15 | view |
| JYSB2000179 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Supplementary Application | 2020-05-16 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Baxter Oncology GmbH;Merck KGaA | In Review | 2020-05-15 | view |
| JYSB2000112 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Supplementary Application | 2020-04-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Baxter Oncology GmbH;Merck Healthcare KGaA | In Review | 2020-04-10 | view |
| JXSL2000002 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2020-01-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2020-01-10 | view |
| JXSL1900155 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2020-01-11 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck Healthcare KGaA | In Review | 2020-01-10 | view |
| JXSL1900054 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2019-06-12 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | In Review | 2019-06-11 | view |
| JXSL1900006 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2019-02-02 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | In Review | 2019-02-01 | view |
| JXSL1800051 | M7824 (MSB0011359C) | bintrafusp alfa | Injection | Biological Products | Import Drug Application | 2018-11-12 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Merck KGaA | In Review | 2018-11-09 | view |
| JYSB1300229 | 螨变应原注射液 | | Injection | Biological Products | Supplementary Application | 2013-09-26 | 默克雪兰诺（北京）医药研发有限公司 | Merck Serono (Beijing) Pharmaceutical R&D Co Ltd;Allergopharma Gmbh & Co KG | Certificate Issued | 2018-09-07 | view |
